Global, regional, and national mortality due to unintentional carbon monoxide poisoning, 2000-2021: results from the Global Burden of Disease Study 2021.


Journal

The Lancet. Public health
ISSN: 2468-2667
Titre abrégé: Lancet Public Health
Pays: England
ID NLM: 101699003

Informations de publication

Date de publication:
11 2023
Historique:
received: 10 03 2023
revised: 04 08 2023
accepted: 08 08 2023
medline: 30 10 2023
pubmed: 10 10 2023
entrez: 9 10 2023
Statut: ppublish

Résumé

Unintentional carbon monoxide poisoning is a largely preventable cause of death that has received insufficient attention. We aimed to conduct a comprehensive global analysis of the demographic, temporal, and geographical patterns of fatal unintentional carbon monoxide poisoning from 2000 to 2021. As part of the latest Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), unintentional carbon monoxide poisoning mortality was quantified using the GBD cause of death ensemble modelling strategy. Vital registration data and covariates with an epidemiological link to unintentional carbon monoxide poisoning informed the estimates of death counts and mortality rates for all locations, sexes, ages, and years included in the GBD. Years of life lost (YLLs) were estimated by multiplying deaths by remaining standard life expectancy at age of death. Population attributable fractions (PAFs) for unintentional carbon monoxide poisoning deaths due to occupational injuries and high alcohol use were estimated. In 2021, the global mortality rate due to unintentional carbon monoxide poisoning was 0·366 per 100 000 (95% uncertainty interval 0·276-0·415), with 28 900 deaths (21 700-32 800) and 1·18 million YLLs (0·886-1·35) across all ages. Nearly 70% of deaths occurred in males (20 100 [15 800-24 000]), and the 50-54-year age group had the largest number of deaths (2210 [1660-2590]). The highest mortality rate was in those aged 85 years or older with 1·96 deaths (1·38-2·32) per 100 000. Eastern Europe had the highest age-standardised mortality rate at 2·12 deaths (1·98-2·30) per 100 000. Globally, there was a 53·5% (46·2-63·7) decrease in the age-standardised mortality rate from 2000 to 2021, although this decline was not uniform across regions. The overall PAFs for occupational injuries and high alcohol use were 13·6% (11·9-16·0) and 3·5% (1·4-6·2), respectively. Improvements in unintentional carbon monoxide poisoning mortality rates have been inconsistent across regions and over time since 2000. Given that unintentional carbon monoxide poisoning is almost entirely preventable, policy-level interventions that lower the risk of carbon monoxide poisoning events should be prioritised, such as those that increase access to improved heating and cooking devices, reduce carbon monoxide emissions from generators, and mandate use of carbon monoxide alarms. Bill & Melinda Gates Foundation.

Sections du résumé

BACKGROUND
Unintentional carbon monoxide poisoning is a largely preventable cause of death that has received insufficient attention. We aimed to conduct a comprehensive global analysis of the demographic, temporal, and geographical patterns of fatal unintentional carbon monoxide poisoning from 2000 to 2021.
METHODS
As part of the latest Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), unintentional carbon monoxide poisoning mortality was quantified using the GBD cause of death ensemble modelling strategy. Vital registration data and covariates with an epidemiological link to unintentional carbon monoxide poisoning informed the estimates of death counts and mortality rates for all locations, sexes, ages, and years included in the GBD. Years of life lost (YLLs) were estimated by multiplying deaths by remaining standard life expectancy at age of death. Population attributable fractions (PAFs) for unintentional carbon monoxide poisoning deaths due to occupational injuries and high alcohol use were estimated.
FINDINGS
In 2021, the global mortality rate due to unintentional carbon monoxide poisoning was 0·366 per 100 000 (95% uncertainty interval 0·276-0·415), with 28 900 deaths (21 700-32 800) and 1·18 million YLLs (0·886-1·35) across all ages. Nearly 70% of deaths occurred in males (20 100 [15 800-24 000]), and the 50-54-year age group had the largest number of deaths (2210 [1660-2590]). The highest mortality rate was in those aged 85 years or older with 1·96 deaths (1·38-2·32) per 100 000. Eastern Europe had the highest age-standardised mortality rate at 2·12 deaths (1·98-2·30) per 100 000. Globally, there was a 53·5% (46·2-63·7) decrease in the age-standardised mortality rate from 2000 to 2021, although this decline was not uniform across regions. The overall PAFs for occupational injuries and high alcohol use were 13·6% (11·9-16·0) and 3·5% (1·4-6·2), respectively.
INTERPRETATION
Improvements in unintentional carbon monoxide poisoning mortality rates have been inconsistent across regions and over time since 2000. Given that unintentional carbon monoxide poisoning is almost entirely preventable, policy-level interventions that lower the risk of carbon monoxide poisoning events should be prioritised, such as those that increase access to improved heating and cooking devices, reduce carbon monoxide emissions from generators, and mandate use of carbon monoxide alarms.
FUNDING
Bill & Melinda Gates Foundation.

Identifiants

pubmed: 37813118
pii: S2468-2667(23)00185-8
doi: 10.1016/S2468-2667(23)00185-8
pmc: PMC10602911
pii:
doi:

Substances chimiques

Carbon Monoxide 7U1EE4V452

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e839-e849

Investigateurs

Madeline E Moberg (ME)
Erin B Hamilton (EB)
Scott M Zeng (SM)
Dana Bryazka (D)
Jeff T Zhao (JT)
Rachel Feldman (R)
Yohannes Habtegiorgis Abate (YH)
Mohsen Abbasi-Kangevari (M)
Ame Mehadi Abdurehman (AM)
Aidin Abedi (A)
Eman Abu-Gharbieh (E)
Isaac Yeboah Addo (IY)
Abiola Victor Adepoju (AV)
Qorinah Estiningtyas Sakilah Adnani (QES)
Saira Afzal (S)
Bright Opoku Ahinkorah (BO)
Sajjad Ahmad (S)
Danial Ahmed (D)
Haroon Ahmed (H)
Dejene Tsegaye Alem (DT)
Adel Ali Saeed Al-Gheethi (AAS)
Yousef Alimohamadi (Y)
Edward Kwabena Ameyaw (EK)
Mohammad Amrollahi-Sharifabadi (M)
Tadele Fentabil Anagaw (TF)
Anayochukwu Edward Anyasodor (AE)
Jalal Arabloo (J)
Aleksandr Y Aravkin (AY)
Seyyed Shamsadin Athari (SS)
Alok Atreya (A)
Amirhossein Azari Jafari (A)
Ashish D Badiye (AD)
Nayereh Baghcheghi (N)
Sara Bagherieh (S)
Hansi Bansal (H)
Amadou Barrow (A)
Azadeh Bashiri (A)
Nebiyou Simegnew Bayileyegn (NS)
Alemshet Yirga Berhie (AY)
Akshaya Srikanth Bhagavathula (AS)
Pankaj Bhardwaj (P)
Archith Boloor (A)
Luis Alberto Cámera (LA)
Felix Carvalho (F)
Márcia Carvalho (M)
Eeshwar K Chandrasekar (EK)
Jung-Chen Chang (JC)
Vijay Kumar Chattu (VK)
Dinh-Toi Chu (DT)
Kaleb Coberly (K)
Natália Cruz-Martins (N)
Omid Dadras (O)
Xiaochen Dai (X)
Reza Darvishi Cheshmeh Soltani (R)
Saswati Das (S)
Subasish Das (S)
Sisay Abebe Debela (SA)
Berecha Hundessa Demessa (BH)
Xinlei Deng (X)
Abebaw Alemayehu Desta (AA)
Belay Desye (B)
Meghnath Dhimal (M)
Mahmoud Dibas (M)
Haneil Larson Dsouza (HL)
Michael Ekholuenetale (M)
Iman El Sayed (I)
Waseem El-Huneidi (W)
Daniel Berhanie Enyew (DB)
Adeniyi Francis Fagbamigbe (AF)
Ali Fatehizadeh (A)
Syeda Anum Fatima Fatima (SAF)
Florian Fischer (F)
Richard Charles Franklin (RC)
Tushar Garg (T)
Tilaye Gebru Gebi (TG)
Urge Gerema (U)
Melaku Getachew (M)
Motuma Erena Getachew (ME)
Farhad Ghamari (F)
Mahaveer Golechha (M)
Pouya Goleij (P)
Sapna Gupta (S)
Veer Bala Gupta (VB)
Vivek Kumar Gupta (VK)
Mehdi Harorani (M)
Hamidreza Hasani (H)
Abbas M Hassan (AM)
Hossein Hassanian-Moghaddam (H)
Mohammed Bheser Hassen (MB)
Simon I Hay (SI)
Khezar Hayat (K)
Mohammad Heidari (M)
Mahsa Heidari-Foroozan (M)
Demisu Zenbaba Heyi (DZ)
Ramesh Holla (R)
Praveen Hoogar (P)
Md Shakhaoat Hossain (MS)
Mohammad-Salar Hosseini (MS)
Sorin Hostiuc (S)
Soodabeh Hoveidamanesh (S)
Olayinka Stephen Ilesanmi (OS)
Irena M Ilic (IM)
Mustapha Immurana (M)
Chidozie C D Iwu (CCD)
Umesh Jayarajah (U)
Nitin Joseph (N)
Charity Ehimwenma Joshua (CE)
Vidya Kadashetti (V)
Tanuj Kanchan (T)
Himal Kandel (H)
Rami S Kantar (RS)
Neeti Kapoor (N)
Ibraheem M Karaye (IM)
Patrick Dmc Katoto (PD)
Himanshu Khajuria (H)
Ejaz Ahmad Khan (EA)
Sorour Khateri (S)
Farzad Khodamoradi (F)
Moein Khormali (M)
Jagdish Khubchandani (J)
Grace Kim (G)
Adnan Kisa (A)
Hamid Reza Koohestani (HR)
Kewal Krishan (K)
Naveen Kumar (N)
Lucie Laflamme (L)
Iván Landires (I)
Bagher Larijani (B)
Paolo Lauriola (P)
Thao Thi Thu Le (TTT)
Caterina Ledda (C)
Seung Won Lee (SW)
Stephen S Lim (SS)
Stany W Lobo (SW)
Raimundas Lunevicius (R)
Sandeep B Maharaj (SB)
Ritesh G Menezes (RG)
Alexios-Fotios A Mentis (AA)
Tomislav Mestrovic (T)
Ted R Miller (TR)
Seyyedmohammadsadeq Mirmoeeni (S)
Awoke Misganaw (A)
Manish Mishra (M)
Sanjeev Misra (S)
Chaitanya Mittal (C)
Esmaeil Mohammadi (E)
Ali H Mokdad (AH)
Mohammad Ali Moni (MA)
Ebrahim Mostafavi (E)
Sumaira Mubarik (S)
Francesk Mulita (F)
Jember Azanaw Mulualem (JA)
Temesgen Mulugeta (T)
Christopher J L Murray (CJL)
Isabella Myers (I)
Biswa Prakash Nayak (BP)
Vinod C Nayak (VC)
Seyed Aria Nejadghaderi (SA)
Huong Lan Thi Nguyen (HLT)
Van Thanh Nguyen (VT)
Hasti Nouraei (H)
Ogochukwu Janet Nzoputam (OJ)
Hassan Okati-Aliabad (H)
Isaac Iyinoluwa Olufadewa (II)
Michal Ordak (M)
Alicia Padron-Monedero (A)
Jagadish Rao Padubidri (JR)
Ashok Pandey (A)
Suman Pant (S)
Utsav Parekh (U)
Shrikant Pawar (S)
Amy E Peden (AE)
Ionela-Roxana Petcu (IR)
Frédéric B Piel (FB)
Zahra Zahid Piracha (ZZ)
Ghazaleh Pourali (G)
Ibrahim Qattea (I)
Maryam Faiz Qureshi (MF)
Pankaja Raghav Raghav (PR)
Mosiur Rahman (M)
Shayan Rahmani (S)
Premkumar Ramasubramani (P)
Sheena Ramazanu (S)
Salman Rawaf (S)
Nazila Rezaei (N)
Negar Rezaei (N)
Mohsen Rezaeian (M)
Basema Saddik (B)
Malihe Sadeghi (M)
Farideh Sadeghian (F)
Umar Saeed (U)
Amirhossein Sahebkar (A)
Zahra Saif (Z)
Joseph W Sakshaug (JW)
Saina Salahi (S)
Payman Salamati (P)
Abdallah M Samy (AM)
Rodrigo Sarmiento-Suárez (R)
David C Schwebel (DC)
Subramanian Senthilkumaran (S)
Allen Seylani (A)
Masood Ali Shaikh (MA)
Sunder Sham (S)
Bereket Beyene Shashamo (BB)
Rahim Ali Sheikhi (RA)
B Suresh Kumar Shetty (BSK)
Pavanchand H Shetty (PH)
Migbar Mekonnen Sibhat (MM)
Harpreet Singh (H)
Paramdeep Singh (P)
Eskinder Ayalew Sisay (EA)
Yonatan Solomon (Y)
Majid Taheri (M)
Irfan Ullah (I)
Sana Ullah (S)
Francesco S Violante (FS)
Linh Gia Vu (LG)
Nuwan Darshana Wickramasinghe (ND)
Arzu Yigit (A)
Naohiro Yonemoto (N)
Zabihollah Yousefi (Z)
Muhammad Zaman (M)
Mikhail Sergeevich Zastrozhin (MS)
Zhi-Jiang Zhang (ZJ)
Peng Zheng (P)
Mohammad Zoladl (M)
Jaimie D Steinmetz (JD)
Theo Vos (T)
Mohsen Naghavi (M)
Kanyin Liane Ong (KL)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests S Afzal reports payment or honoraria from educational events and webinars with King Edward Medical University, Lahore, Pakistan, and collaborative partners including: Johns Hopkins University, Baltimore, MD, USA; University of California, CA, USA; University of Massachusetts, Boston, MA, USA; and University of Lahore, Lahore, Pakistan; participation on a data safety monitoring board or advisory board with the National Bioethics Committee Pakistan, King Edward Medical University Institutional Ethical Review Board, Fatima Jinnah Medical University, Lahore, Pakistan; and Sir Ganga Ram Hospital, Delhi, India; leadership or fiduciary roles in board, society, committee, or advocacy groups, paid or unpaid, with the Pakistan Association of Medical Editors, Fellow of Faculty of Public Health Royal Colleges UK, Society of Prevention, Advocacy and Research, King Edward Medical University, and as a member of the Pakistan Society of Infectious Diseases; outside the submitted work. M Carvalho reports grants or contracts from Fundação para a Ciência e a Tecnologia in the scope of the project UIDP/04378/2020 and UIDB/04378/2020 of the Research Unit on Applied Molecular Biosciences, and project LA/P/0140/2020 of i4HB; outside the submitted work. R C Franklin reports grants or contracts from Heatwaves in Queensland, Queensland Government; Arc Flash, Human Factors, Queensland Government; and Mobile Plant Safety, AgriFutures; honoraria from the World Safety Conference 2022- Conference Convener; support for attending the ACTM Tropical Medicine and Travel Medicine Conference 2022 and ISTM Travel Medicine Conference 2023 in Basel; leadership or fiduciary roles in board, society, committee, or advocacy groups, paid or unpaid, with Kidsafe as a Director, Auschem as a Director, ISASH on the Governance Committee, Farmsafe as a Director, and PHAA Injury Prevention SIG as a Convenor; outside the submitted work. K Krishan reports other, non-financial support from the UGC Centre of Advanced Study, CAS II, Department of Anthropology, Panjab University, Chandigarh, India; outside the submitted work. A-F A Mentis reports funding from MilkSafe: a novel pipeline to enrich formula milk using omics technologies, a research co-financed by the European Regional Development Fund of the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call Research–Create–Innovate (project code: T2EDK-02222), and from ELIDEK (Hellenic Foundation for Research and Innovation, MIMS-860); payment or expert testimony as an external peer reviewer for Fondazione Cariplo, Italy; leadership or fiduciary roles in board, society, committee, or advocacy groups, paid or unpaid, with Systematic Reviews journal as an editorial board member, Annals of Epidemiology and Translational Psychiatry journal as Associate Editor; and other financial or non-financial support as a scientific officer at the BGI Group; outside the submitted work. I Myers reports research grants from CO Research Trust; payment or honoraria from CO Research Trust; support for attending meetings from CO Research Trust; leadership roles in board, society, committee, or advocacy groups, unpaid, with UK All Party Parliamentary CO Group Medical Sub-Group as a Chair, UK Indoor Environments Group as a Committee Member, and OFGEM DRS-GDN as a panel member; outside the submitted work. A E Peden reports support for this paper from The Australian National Health and Medical Research Council Emerging Leadership Fellowship (APPID: APP2009306).

Références

Am J Emerg Med. 2010 Oct;28(8):928-32
pubmed: 20825926
Environ Health. 2022 Apr 2;21(1):38
pubmed: 35365149
Public Health Rep. 2011 May-Jun;126 Suppl 1:100-7
pubmed: 21563717
CMAJ Open. 2015 Apr 02;3(2):E223-30
pubmed: 26389101
J Family Med Prim Care. 2017 Oct-Dec;6(4):791-794
pubmed: 29564265
BMJ Open. 2021 Nov 17;11(11):e053240
pubmed: 34789496
Am J Public Health. 2012 Oct;102(10):1957-63
pubmed: 22897556
Indoor Air. 2013 Apr;23(2):115-25
pubmed: 23025441
Ann Work Expo Health. 2017 Oct 01;61(8):986-993
pubmed: 29028252
Bull World Health Organ. 2023 Jul 1;101(7):470-477
pubmed: 37397170
BMC Med Inform Decis Mak. 2021 Jun 2;21(1):175
pubmed: 34078366
Int J Inj Contr Saf Promot. 2011 Dec;18(4):313-20
pubmed: 21827338
Popul Health Metr. 2012 Jan 06;10:1
pubmed: 22226226
BMC Public Health. 2019 Jan 3;19(1):9
pubmed: 30606153
Am J Emerg Med. 2015 Sep;33(9):1140-5
pubmed: 26032660
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
Arch Environ Occup Health. 2005 May-Jun;60(3):119-27
pubmed: 17153084
Int J Environ Res Public Health. 2021 Aug 22;18(16):
pubmed: 34444603
Front Public Health. 2022 Jul 28;10:930784
pubmed: 35968482
Environ Sci Pollut Res Int. 2022 Jan;29(5):6911-6928
pubmed: 34467490
Lancet. 2020 Oct 17;396(10258):1160-1203
pubmed: 33069325
Front Public Health. 2021 Oct 14;9:718846
pubmed: 34722435
Am J Respir Crit Care Med. 2017 Mar 1;195(5):596-606
pubmed: 27753502
Public Health Rep. 2007 Mar-Apr;122(2):138-44
pubmed: 17357355
Am J Public Health. 2015 Aug;105(8):1623-9
pubmed: 26066948
Lancet. 2016 Dec 10;388(10062):e19-e23
pubmed: 27371184
Physiol Rep. 2014 Dec 11;2(12):
pubmed: 25501428
Am J Ind Med. 2013 Nov;56(11):1280-9
pubmed: 23868822
Hum Exp Toxicol. 2020 Apr;39(4):387-392
pubmed: 31789062
J Public Health Res. 2021 Aug 13;11(1):
pubmed: 35166092
Ann Emerg Med. 2023 Mar;81(3):309-317
pubmed: 36585319
JAMA. 1998 Mar 4;279(9):685-7
pubmed: 9496987
Undersea Hyperb Med. 2016 May-Jun;43(3):207-15
pubmed: 27416688
Age Ageing. 2004 Mar;33(2):105-9
pubmed: 14960423
J Environ Health. 2011 Jan-Feb;73(6):30-3
pubmed: 21306092
Dtsch Arztebl Int. 2018 Dec 24;115(51-52):863-870
pubmed: 30765023
Int J Environ Res Public Health. 2022 Mar 30;19(7):
pubmed: 35409782
Inj Prev. 2013 Apr;19(2):119-23
pubmed: 22653781
Am J Emerg Med. 1996 Sep;14(5):484-6
pubmed: 8765117
Epidemiol Health. 2020;42:e2020062
pubmed: 32882118
J Anaesthesiol Clin Pharmacol. 2022 Jul;38(Suppl 1):S151-S153
pubmed: 36060171
BMJ Open Qual. 2022 Jun;11(2):
pubmed: 35675945
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
J Forensic Leg Med. 2018 Jan;53:87-96
pubmed: 29220732
Folia Med Cracov. 2021 Sep 29;61(3):21-31
pubmed: 34882661
Ann Am Thorac Soc. 2016 Oct;13(10):1768-1774
pubmed: 27466698
Indoor Air. 2007 Dec;17(6):468-74
pubmed: 18045271
Toxicology. 2000 Apr 7;145(1):1-14
pubmed: 10771127

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH